153 related articles for article (PubMed ID: 32284750)
1. RAS/RAF mutations in tumor samples and cell-free DNA from plasma and bone marrow aspirates in multiple myeloma patients.
Li Q; Huang HJ; Ma J; Wang Y; Cao Z; Karlin-Neumann G; Janku F; Liu Z
J Cancer; 2020; 11(12):3543-3550. PubMed ID: 32284750
[No Abstract] [Full Text] [Related]
2. Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction.
Janku F; Huang HJ; Fujii T; Shelton DN; Madwani K; Fu S; Tsimberidou AM; Piha-Paul SA; Wheler JJ; Zinner RG; Naing A; Hong DS; Karp DD; Cabrilo G; Kopetz ES; Subbiah V; Luthra R; Kee BK; Eng C; Morris VK; Karlin-Neumann GA; Meric-Bernstam F
Ann Oncol; 2017 Mar; 28(3):642-650. PubMed ID: 27993791
[TBL] [Abstract][Full Text] [Related]
3. Liquid Biopsies Using Plasma Exosomal Nucleic Acids and Plasma Cell-Free DNA Compared with Clinical Outcomes of Patients with Advanced Cancers.
Möhrmann L; Huang HJ; Hong DS; Tsimberidou AM; Fu S; Piha-Paul SA; Subbiah V; Karp DD; Naing A; Krug A; Enderle D; Priewasser T; Noerholm M; Eitan E; Coticchia C; Stoll G; Jordan LM; Eng C; Kopetz ES; Skog J; Meric-Bernstam F; Janku F
Clin Cancer Res; 2018 Jan; 24(1):181-188. PubMed ID: 29051321
[No Abstract] [Full Text] [Related]
4. Detection of
Michaelidou K; Koutoulaki C; Mavridis K; Vorrias E; Papadaki MA; Koutsopoulos AV; Mavroudis D; Agelaki S
Cells; 2020 Nov; 9(11):. PubMed ID: 33233668
[No Abstract] [Full Text] [Related]
5. Identification of an optimal mutant allele frequency to detect activating
Caughey BA; Umemoto K; Green MF; Ikeda M; Lowe ME; Ueno M; Niedzwiecki D; Taniguchi H; Walden DJ; Komatsu Y; D'Anna R; Esaki T; Denda T; Datto MB; Bando H; Bekaii-Saab T; Yoshino T; Strickler JH; Nakamura Y
J Gastrointest Oncol; 2023 Oct; 14(5):2083-2096. PubMed ID: 37969845
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates.
Kis O; Kaedbey R; Chow S; Danesh A; Dowar M; Li T; Li Z; Liu J; Mansour M; Masih-Khan E; Zhang T; Bratman SV; Oza AM; Kamel-Reid S; Trudel S; Pugh TJ
Nat Commun; 2017 May; 8():15086. PubMed ID: 28492226
[TBL] [Abstract][Full Text] [Related]
7. The use of cell free DNA (cfDNA) for mutational screening of multiple myeloma.
Marivel AJ; Ma Y; Becker TM; Verma A; Trieu S; Roberts TL; Ling SCW
Leuk Res Rep; 2023; 20():100393. PubMed ID: 37908506
[TBL] [Abstract][Full Text] [Related]
8. Assessment of RAS-RAF-MAPK Pathway Mutation Status in Healthy Skin, Benign Nevi, and Cutaneous Melanomas: Pilot Study Using Droplet Digital PCR.
Dobre EG; Nichita L; Popp C; Zurac S; Neagu M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396984
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-associated clonal hematopoiesis mutations should be taken seriously in plasma cell-free DNA KRAS/NRAS/BRAF genotyping for metastatic colorectal cancer.
Huang F; Yang Y; Chen X; Jiang H; Wang H; Shen M; Yu Y; Liu T; Pan B; Wang B; Guo W
Clin Biochem; 2021 Jun; 92():46-53. PubMed ID: 33737000
[TBL] [Abstract][Full Text] [Related]
10.
Kim Y; Park SS; Min CK; Lee GD; Son J; Jo SJ; Han E; Han K; Kim M
Blood Res; 2020 Sep; 55(3):159-168. PubMed ID: 32989177
[TBL] [Abstract][Full Text] [Related]
11. Multivariate Risk Analysis of RAS, BRAF and EGFR Mutations Allelic Frequency and Coexistence as Colorectal Cancer Predictive Biomarkers.
Ionescu A; Bilteanu L; Geicu OI; Iordache F; Stanca L; Pisoschi AM; Miron A; Serban AI; Calu V
Cancers (Basel); 2022 Jun; 14(11):. PubMed ID: 35681771
[TBL] [Abstract][Full Text] [Related]
12. Plasma cell myeloma with RAS/BRAF mutations is frequently associated with a complex karyotype, advanced stage disease, and poorer prognosis.
Li N; Lin P; Zuo Z; You MJ; Shuai W; Orlowski R; Manasanch EE; Li S; Xu J; Garces S; Jelloul FZ; Tang Z; Wang W; Medeiros LJ; Yin CC
Cancer Med; 2023 Jul; 12(13):14293-14304. PubMed ID: 37212518
[TBL] [Abstract][Full Text] [Related]
13. The potential of PIK3CA, KRAS, BRAF, and APC hotspot mutations as a non-invasive detection method for colorectal cancer.
Alizadeh-Sedigh M; Mahmoodzadeh H; Fazeli MS; Haddadi-Aghdam M; Teimoori-Toolabi L
Mol Cell Probes; 2022 Jun; 63():101807. PubMed ID: 35296442
[TBL] [Abstract][Full Text] [Related]
14. Analytical and clinical validation of a novel amplicon-based NGS assay for the evaluation of circulating tumor DNA in metastatic colorectal cancer patients.
Wang B; Wu S; Huang F; Shen M; Jiang H; Yu Y; Yu Q; Yang Y; Zhao Y; Zhou Y; Pan B; Liu T; Guo W
Clin Chem Lab Med; 2019 Sep; 57(10):1501-1510. PubMed ID: 31339850
[TBL] [Abstract][Full Text] [Related]
15. Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors.
Mehrotra M; Singh RR; Loghavi S; Duose DY; Barkoh BA; Behrens C; Patel KP; Routbort MJ; Kopetz S; Broaddus RR; Medeiros LJ; Wistuba II; Luthra R
Oncotarget; 2018 Feb; 9(12):10259-10271. PubMed ID: 29535804
[TBL] [Abstract][Full Text] [Related]
16. Detection of mutations in circulating cell-free DNA in relation to disease stage in colorectal cancer.
Liebs S; Keilholz U; Kehler I; Schweiger C; Haybäck J; Nonnenmacher A
Cancer Med; 2019 Jul; 8(8):3761-3769. PubMed ID: 31134762
[TBL] [Abstract][Full Text] [Related]
17. Mutation-Enrichment Next-Generation Sequencing for Quantitative Detection of
Fujii T; Barzi A; Sartore-Bianchi A; Cassingena A; Siravegna G; Karp DD; Piha-Paul SA; Subbiah V; Tsimberidou AM; Huang HJ; Veronese S; Di Nicolantonio F; Pingle S; Vibat CRT; Hancock S; Berz D; Melnikova VO; Erlander MG; Luthra R; Kopetz ES; Meric-Bernstam F; Siena S; Lenz HJ; Bardelli A; Janku F
Clin Cancer Res; 2017 Jul; 23(14):3657-3666. PubMed ID: 28096270
[No Abstract] [Full Text] [Related]
18. Serum-Based KRAS
Kim JS; Bae GE; Kim SH; Choi MK; Yeo MK
Front Oncol; 2020; 10():604772. PubMed ID: 33585224
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and detection of actionable BRAF V600 and NRAS Q61 mutations in malignant peripheral nerve sheath tumor by droplet digital PCR.
Kao EY; Wakeman KM; Wu Y; Gross JM; Chen EY; Ricciotti RW; Liu YJ; Mantilla JG
Hum Pathol; 2022 Nov; 129():90-97. PubMed ID: 36067829
[TBL] [Abstract][Full Text] [Related]
20. Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients.
Xu X; Yu Y; Shen M; Liu M; Wu S; Liang L; Huang F; Zhang C; Guo W; Liu T
BMC Cancer; 2020 Oct; 20(1):1006. PubMed ID: 33066758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
